Press release - Mindpeak receives 2m€ funding

June 18, 2020
Hamburg start-up Mindpeak receives funding of 2 million Euros. The Hamburg-based start-up Mindpeak has successfully raised grant funding totalling around 2 million euros. The funding comes from the EU Commission's Horizon 2020 program and the Profi Transfer funding pool of the Hamburg Investment and Development Bank.

Hamburg start-up Mindpeak receives funding of 2 million Euros

The Hamburg-based start-up Mindpeak has successfully raised grant funding totalling around 2 million euros. The funding comes from the EU Commission's Horizon 2020 program and the Profi Transfer funding pool of the Hamburg Investment and Development Bank. Via image recognition systems, Mindpeak’s proprietary algorithms help increase the productivity of pathology labs in clinical routine and promise to support pathologists in their work to precisely diagnose cancers based on digital slides. Mindpeak cooperates with renowned research institutions such as the Charité Berlin and laboratories in Hamburg and Cambridge. The company's solution is immediately ready for use in the laboratory setting without the need for any complex pre-adjustment.

"I am very pleased about these funding commitments. They are proof of the innovative power of our research and products and of the strong endorsement by the European Union and the City of Hamburg in our recent traction and goal to deliver fast, reliable and widely accessible cancer diagnostic tools," said Mindpeak's Managing Director Felix Faber. Faber founded the company two years ago with his partner Dr. Tobias Lang. Mindpeak currently employs 25 people and has already launched the first products for the identification and quantification of breast cancer cells.

"The highly selective funding from the EU program Horizon 2020 and Profi Transfer confirm our investment in Mindpeak as a very innovative startup in the area of cancer diagnostics," said Gencer Sahin, Investment Manager at IFB Innovationsstarter GmbH.

Funds from the EU Horizon 2020 EIC (Enhanced European Innovation Council) program are used to support start-ups as well as small and medium-sized companies that develop highly innovative ideas with an exceptionally large market potential. The Profi Transfer program of the Hamburg Investment and Promotion Bank (IFB) supports the transfer of technology and knowledge between companies and universities or research institutions with grants. Mindpeak received IFB's funding to support its close cooperation towards the development of AI-supported cancer diagnostics with the renowned Institute for Haematopathology Hamburg. "The funds will be used on the one hand to further develop and continuously improve our algorithm for the detection of specific cancer types such as breast cancer at present, as well as to extend the application of our machine learning models to new cancer types," explained Faber.

Press Release

Related reading

Press Release
8 min read

Accelerating AI Adoption in Pathology: Mindpeak x PathGroup

The role of AI in pathology isn’t just evolving – it’s accelerating. It’s helping pathologists turn complex data into faster, more consistent answers for patients. At Mindpeak, we’re proud to be part of that change. Today, we’re taking another big step forward through a new collaboration with PathGroup – one of the leading providers of anatomic, clinical, molecular and digital pathology services in the U.S.

This partnership goes beyond collaboration; it marks a powerful step toward bringing AI into everyday diagnostics. By combining Mindpeak’s proprietary image analysis technology with PathGroup’s extensive, pathologist-led network, we’re laying the groundwork for a new era of precision and efficiency in pathology.

Together, we’ll support pathologists integrate AI seamlessly into their workflows – enhancing speed, consistency and equity in diagnostics. The result: faster, more reliable insights for patients and more time for pathologists to focus on what matters most – patient care.

At Mindpeak, we believe the future of pathology is AI-augmented, not AI-replaced. Through partnerships like this, that future is becoming reality – one slide at a time.

Read more here

Press Release
8 min read

PhenoScout AI: Advancing mIF Analysis

We’re proud to introduce PhenoScout AI, our next-generation multiplex immunofluorescence (mIF) analysis solution.

By automating phenotype identification, biomarker quantification, and spatial readouts, PhenoScout AI reduces variability and supports large-scale studies. The solution is designed for pharma, diagnostics, and academic research to accelerate translational medicine.

👉 Learn more

Press Release
8 min read

Mindpeak Welcomes Christiaan Neeleman to the Board of Directors

We are delighted to announce that Christiaan Neeleman has joined Mindpeak’s Board of Directors.

With more than 20 years of international leadership experience in life sciences, diagnostics, and health technology - including senior roles at Discovery Life Sciences, Definiens, and Philips Healthcare - Christiaan brings deep expertise that will help accelerate our global expansion.

His proven track record in biomarker development, companion diagnostics, and scaling precision diagnostics businesses aligns perfectly with Mindpeak’s mission: enabling faster, more accurate cancer diagnostics through AI-powered pathology.

We are excited to collaborate with Christiaan as we strengthen partnerships, expand into new markets, and further drive the adoption of AI across clinical and research settings.

Read the full press release here

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting